Beasley, Allen, Crow, Methvin, Portis & Miles, P.C., attorney Ted Meadows, who practices in the firm’s Mass Torts section, has been chosen to help direct litigation related to Hormone Replacement Therapy (HRT) as part of the Plaintiffs Steering Committee (PSC).

Wesley Chadwick Cook has been selected to serve on Plaintiffs Steering Committee (PSC) for the consolidated litigation of cases involving the Fosamax Femur Fracture multidistrict litigation (MDL)

Montgomery based law firm Beasley, Allen, Crow, Methvin, Portis and Miles, P.C., has filed a second wrongful death lawsuit involving IV packs filled with liquid nutritional supplements that were contaminated. The lawsuit is filed on behalf of Lyndal Robinson, whose mother, Jewell Robinson, died after receiving contaminated total parenteral nutrition (TPN) at Shelby Baptist Medical Center in Shelby County, Alabama. The lawsuit names Birmingham-based pharmaceutical supplier Meds I.V. LLC as the primary defendant.

Montgomery based law firm Beasley, Allen, Crow, Methvin, Portis and Miles, P.C., has filed a wrongful death lawsuit on behalf of the family of a patient who died in an Alabama hospital after receiving intravenous (IV) fluid tainted with a bacterial infection. The lawsuit is filed on behalf of Barbara Young, whose mother, Mary Ellen Kise, died at Baptist Health Systems in Prattville, Ala.

Beasley, Allen, Crow, Methvin, Portis & Miles, P.C. attorney Navan Ward, Jr., who practices in the firm's Mass Torts section, has been chosen to help direct litigation related to the recall of 93,000 defective hip implant parts. Ward is one of 19 lawyers selected to oversee the consolidated litigation as part of the Plaintiffs Steering Committee (PSC).

Letters written in July 2000 by sales representatives of Wyeth-Ayerst Laboratories, a division of Pfizer pharmaceutical company, have recently been made public. The letters, addressed to Wyeth executives and to their Office of Ethics and Business Conduct, express serious concerns by Wyeth employees that the company encouraged and even required its drug sales reps to minimize any risk of breast cancer and promote dangerous off-label usage of its hormone replacement therapy (HRT) drugs, Premarin and Prempro. These off label uses were never approved by the U.S. Food & Drug Administration (FDA).

Connie Barton and Donna Kendall have something in common:  they stood up to one of the largest and most powerful drug companies in court - and won.  Today in Philadelphia, Penn., their verdicts against Wyeth (a division of Pfizer) over its hormone therapy drugs Premarin and Prempro were released.  In each case, the jury awarded the women significant compensatory and punitive damages ranging from more than $34 million to $78 million.  This is just the tip of the iceberg as Wyeth faces lawsuits from more than 10,000 additional women who also claim that Wyeth's drugs gave them breast cancer.

Merck & Co., Inc. has agreed to pay $4.85 billion to resolve Vioxx related claims in which a claimant has suffered a heart attack, sudden cardiac death, or stroke.

Judge Eldon E. Fallon, presiding judge over the federal Vioxx consolidated proceedings, In re Vioxx Products Liability Litigation MDL (No. 1657), ordered a new trial today in Evelyn Irvin Plunkett v. Merck & Co. Judge Fallon, a United States District Judge for the Eastern District of Louisiana, found that there was clear and convincing evidence that during the second trial of the Irvin case, Merck's expert cardiologist, Dr. Barry Rayburn, misrepresented his qualifications to the Court and to the jury.

Hundreds of local women are receiving letters, citing an American College of Gynecology study exposing the greater risk of deep vein thrombosis in women using the Ortho Evra birth control patch.